87 related articles for article (PubMed ID: 17074152)
1. [Expression of tissue microarray p53, p16 and cyclooxygenase-2 in gastric cancer].
Yu CH; Li L; Li YM; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):658-60. PubMed ID: 17074152
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.
Liu YS; Yu CH; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Li YM; Jun Gao H
J Dig Dis; 2007 Aug; 8(3):133-8. PubMed ID: 17650224
[TBL] [Abstract][Full Text] [Related]
3. [Detection of expression of p53, p16, and cyclooxygenase 2 in pancreatic cancer by tissue microarray and correlation among these three genes].
Li YM; Yu ZH; Li L; Xu P; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):939-42. PubMed ID: 16759529
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.
Xu L; Li YM; Yu CH; Li L; Liu YS; Zhang BF; Fang J; Zhou Q; Hu Y; Gao HJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):138-42. PubMed ID: 16481301
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
7. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
8. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.
Chen YJ; Shih LS; Chen YM
Int J Oncol; 1998 Aug; 13(2):249-54. PubMed ID: 9664118
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression correlates with nuclear p53 accumulation in gastric carcinoma.
Shun CT; Wu MS; Huang SP; Wang HP; Chuang SM; Lin JT
Hepatogastroenterology; 2003; 50(52):988-92. PubMed ID: 12845964
[TBL] [Abstract][Full Text] [Related]
11. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
12. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
13. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between Helicobacter pylori infection and expressions of tumor suppressor genes in gastric carcinoma and related lesions].
Tian SF; Xiong YY; Yu SP; Lan J
Ai Zheng; 2002 Sep; 21(9):970-3. PubMed ID: 12508544
[TBL] [Abstract][Full Text] [Related]
15. [The expression of suppressor gene p16, p21 and p53 in nasopharyngeal carcinoma].
Lei X; Zhou Y; He X; Chen F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Sep; 13(9):406-8. PubMed ID: 12541388
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PTEN, p16, p21, and p53 proteins in lung cancer using tissue microarray and their clinical significance].
Liao XB; Hu DX; Zhou XM; Yu FL; Yuan YC; Chen MJ
Ai Zheng; 2004 Mar; 23(3):334-8. PubMed ID: 15025970
[TBL] [Abstract][Full Text] [Related]
17. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
